Tandem Diabetes Care (TNDM) Tax Rate Growth (5y) (2023 - 2026)
Tandem Diabetes Care (TNDM) Tax Rate Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Tandem Diabetes Care | 1.15 Bn | 575.39 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -444.00 |
| Sep 30, 2025 | 1,624.00 |
| Jun 30, 2025 | 923.00 |
| Mar 31, 2025 | -630.00 |
| Dec 31, 2024 | -462,157.00 |
| Sep 30, 2024 | -11.00 |
| Dec 31, 2023 | 293.00 |